Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1994-11-08
1997-12-02
Jagannathan, Vasu S.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
530399, 930120, 514 12, C07H 2104, C07K 1451, C12N 1512, A61K 3818
Patent
active
056937792
ABSTRACT:
An isolated polynucleotide of anti-dorsalizing morphogenetic protein (ADMP-1) is obtained from Xenopus. The protein is most closely related to human BMP-3. ADMP-1 functions as a modulator for dorsalizing influences, and prevents syndromes involving inappropriate proliferation of tissues.
REFERENCES:
patent: 5279966 (1994-01-01), Jessell et al.
Harland et al "The Transforming Growth Factor .beta. Family . . . " PNAS 91(22):10243-10246 (Oct. 1994).
Basler et al, "Control of Cell Pattern in the Neural Tube . . . " Cell 73:687-702 (May 1993).
Christian et al, "Xwnt-8 Modifies the Character of Mesoderm . . . " EMBO J 11(1):33-4 (1992).
Smith et al, "Injected Xwnt-8 RNA Acts Early in Xenopus . . . " Cell 67:753-765 (Nov. 1991).
Berkow et al, The Merck Manual, pp. 1387-1388, 1606-1607, 1961-1962.
Krinks Marie
Moos, Jr. Malcolm
Wang Shouwen
Jagannathan Vasu S.
Romeo David
The United States of America as represented by the Department of
LandOfFree
Production and use of anti-dorsalizing morphogenetic protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Production and use of anti-dorsalizing morphogenetic protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production and use of anti-dorsalizing morphogenetic protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-802729